Christine Dolan serves as the General Manager of Cygnus Technologies at Maravai LifeSciences Holdings Inc., where she plays a pivotal role in advancing the company's mission to provide critical products and services to the life sciences industry. With a robust background in biotechnology and life sciences, Dolan has been instrumental in steering Cygnus Technologies towards innovation and excellence. Her leadership at Cygnus Technologies focuses on developing and commercializing high-quality reagents and kits that are essential for bioprocessing and biopharmaceutical production. Prior to her role at Maravai LifeSciences, Dolan accumulated extensive experience in the biotech sector, working with various organizations where she honed her skills in product development, strategic planning, and team leadership. Her career is marked by significant achievements, including the successful launch of several innovative products that have contributed to advancements in biopharmaceutical research and development. Dolan's strategic vision and dedication to quality have been key drivers in her ability to lead Cygnus Technologies to new heights. At Maravai LifeSciences, Dolan's responsibilities include overseeing the operational aspects of Cygnus Technologies, ensuring that the division meets its goals in terms of product quality, innovation, and customer satisfaction. Her commitment to excellence and her ability to foster a collaborative work environment have made her an invaluable asset to the company. Under her guidance, Cygnus Technologies continues to be a leader in providing solutions that support the development and manufacturing of biopharmaceuticals, contributing significantly to Maravai LifeSciences' overall success.